Ocugen
- Biotech or pharma, therapeutic R&D
Ocugen is a pioneering biotechnology leader in gene therapies for blindness diseases. We are making an impact on patients’ lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product. We are planning to potentially file three BLAs/MAAs in next three years targeting RP, Stargardt, and dry AMD (late stage - GA).
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}